Exact Mass: 444.2809

1,25-Dihydroxyvitamin D3-26,23-lactone

(3R,5S)-5-[(2R)-2-[(1R,3aS,4E,7aR)-4-{2-[(1Z,3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]propyl]-3-hydroxy-3-methyloxolan-2-one

1,25-Dihydroxyvitamin D3-26,23-lactone (1,25(OH)2D3-26,23-lactone) is a vitamin D3 metabolite. The formation of 1,25(OH)2D3-26,23-lactone occurs in normocalcemic states and in situations in which 1,25(OH)2D3 has been administered. (PMID: 6324253). 1,25-dihydroxyvitamin D3 and (23S)-1,23,25-trihydroxyvitamin D3 are efficient precursors to 1,25(OH)2D3-26,23-lactone. 1,25(OH)2D3-26,23-lactone has an inhibitory action of bone resorption and the lactone ring plays a major part in its expression. (PMID: 6548386, 1666030). 1,25-Dihydroxyvitamin D3-26,23-lactone (1,25(OH)2D3-26,23-lactone) is a vitamin D3 metabolite. The formation of 1,25(OH)2D3-26,23-lactone occurs in normocalcemic states and in situations in which 1,25(OH)2D3 has been administered. (PMID: 6324253) D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

17-hydroxyprogesterone caproate

14-acetyl-14-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-3-yl hexanoate

Calcitriol lactone

5-(2-{4-[2-(3,5-dihydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-hexahydro-1H-inden-1-yl}propyl)-3-hydroxy-3-methyloxolan-2-one

Proliferin

2-{2,13-dihydroxy-3a,6,10,14-tetramethyl-3-oxo-3H,3ah,4H,7H,8H,11H,12H,13H,16H,16ah-cyclopenta[15]annulen-1-yl}propyl acetic acid

MG(6 keto-PGF1alpha/0:0/0:0)

(2S)-2,3-Dihydroxypropyl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoic acid

MG(6 keto-PGF1alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(TXB2/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

MG(TXB2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/6 keto-PGF1alpha/0:0)

1,3-dihydroxypropan-2-yl 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoate

MG(0:0/6 keto-PGF1alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/TXB2/0:0)

1,3-Dihydroxypropan-2-yl (5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid

MG(0:0/TXB2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

The 12-epimer of scalarin, a metabolite of marine sponges of the genus Spongia.

3-Acetylsesterstatin

Asparacosin A

(25R)-3-dioxo-spirost-5-en-12beta,17alpha-diol

Foetidinol

Spirosta-5,25(27)-diene-1beta,3beta,11alpha-triol

Thorectandrol B

S-15183b

Sesterstatin 7

Thorectandrol C

12beta-Acetoxy-20-hydroxy-17-scalaren-19,20-olide

(19R)-9-acetyl-19-hydroxy-10,14-dimethyl-20-oxopentacyclo[11.8.0.0<2,10>.0<4,9 >.0<14,19>]henicos-17-yl acetate

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.480 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.475 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.479 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.476

Chinensin I

3-acetylsesterstatin 1

15-Dehydro-14beta-anosmagenin

Kammogenin

(25R)-2alpha,3beta-dihydroxy-spirost-5-en-12-one

12-amino-6,9-di-sec-butyl-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione

12-O-acetyl-16-O-deacetyl-12,16-episcalarolbutenolide|12alpha-acetoxy-16beta-hydroxyscalarolbutenolide

C27H40O5

3beta.27-Dihydroxy-25betaFH-cholesten-(5)-trion-(12.16.22)|3beta.27-dihydroxy-25betaFH-cholestene-(5)-trione-(12.16.22)

Lowegenin

Afurigenin

geranyl-1-O-alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranoside

12-deacetoxy-23-acetoxy-19-O-acetylscalarin|12-deacetoxy-23-acetoxyscalarin

(25R)-2alpha,3beta-Dihydroxy-5alpha-spirost-9(11)-en-12-on|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9(11)-en-12-one|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one|9(11)-Dehydromanogenin|9-dehydromanogenin

(25R)-2alpha,3beta-Dihydroxy-5alpha-spirost-9(11)-en-12-on|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9(11)-en-12-one|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one|9(11)-Dehydromanogenin|9-dehydromanogenin

Amphidinolide K

6-keto-deoxoscalarin

(25S)-17alpha,25-dihydroxyspirost-4-en-3-one|diosbulbisin B

12-epideoxoscalarin-3-one

inorolide C

Sansevierigenin

Delta25(27)-Manogenin

24-O-ethylmanoalide

(6R)-3,5-dihydroxy-4-<<(1S,2R,5R)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl>methyl>-6-methyl-2-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one|(6R)-3,5-dihydroxy-4-{[(1S,2R,5R)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl]methyl}-6-methyl-2-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one

(6R*)-3,5-dihydroxy-4-<<(1S*,2R*,5R*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl>methyl>-6-methyl-2-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one|(6R*)-3,5-dihydroxy-4-{[(1S*,2R*,5R*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl]methyl}-6-methyl-2-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one

inorolide A

meroterphenol C

chevalone D

yojironin F

yojironin E

yojironin G

Linarienone

8-methylhomobotcinolide

1-Acetoxy-3-methylene-6a,9,9,12a,14-pentamethyl-8-hydroxy-4,5-butano-2,3,4,5,6a,7,8,8a,9,10,11,12,12a,12b-tetradecahydro-1H-naphtho[2,1-b]oxocin-13-ene-15-one

(22S,25S)-17alpha,26-dihydroxy-22,25-epoxyfurost-4-en-3-one|diosbulbisin C

25-Hydroxy-tamusgenin

petiolin M

chinesin I

luffarin-D

C23H40O8

16-(2,5-dihydroxy-3-methylphenyl)-14-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10-trienoic acid

Nummularogenin

18R-acetoxy-20-hydroxy-2,10,19(21)-cladocoratrien-22(20)-olide|cladocoran A

Trp Ile Leu

Trp Leu Ile

Ile Leu Trp

Leu Ile Trp

Ile Trp Leu

Scalarin

A scalarane sesterterpenoid lactone, a metabolite of marine sponges of the family Thorectidae (order dictyoceratida).

Fusaproliferin_130137

C27H40O5_(2alpha,3beta,5alpha,8xi,14xi,25S)-2,3-Dihydroxyspirost-9(11)-en-12-one

NCGC00384758-01_C27H40O5_(2alpha,3beta,5alpha,8xi,14xi,25S)-2,3-Dihydroxyspirost-9(11)-en-12-one

Ala Ala Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]hexanamido]-5-carbamimidamidopentanoic acid

Ala Ala Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-5-carbamimidamidopentanamido]hexanoic acid

Ala Lys Ala Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]propanamido]-5-carbamimidamidopentanoic acid

Ala Lys Arg Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-5-carbamimidamidopentanamido]propanoic acid

Ala Arg Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]propanamido]hexanoic acid

Ala Arg Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]hexanamido]propanoic acid

Lys Ala Ala Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]propanamido]pentanoic acid

Lys Ala Arg Ala

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]pentanamido]propanoic acid

Lys Arg Ala Ala

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]propanamido]propanoic acid

Arg Ala Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]propanamido]hexanoic acid

Arg Ala Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]hexanamido]propanoic acid

Arg Lys Ala Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]propanamido]propanoic acid

6-keto-PGF1a-G

6-oxo-9S,11R,15S-trihydroxy-13E-prostenoic acid 1(3)-glyceryl ester

2-glyceryl-6-keto-PGF1&alpha

6-oxo-9S,11R,15S-trihydroxy-13E-prostenoic acid 2-glyceryl ester

(23S,25R)-25-hydroxyvitamin D3 26,23-peroxylactone / (23S,25R)-25-hydroxycholecalciferol 26,23-peroxylactone

(5Z,7E)-(1S,3R,23R,25R)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone

(23R,25R)-1α,25-dihydroxyvitamin D3 26,23-lactone / (23R,25R)-1α,25-dihydroxycholecalciferol 26,23-lactone

(5Z,7E)-(1S,3R,23S,25R)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone

(23S,25R)-1α,25-dihydroxyvitamin D3 26,23-lactone / (23S,25R)-1α,25-dihydroxycholecalciferol 26,23-lactone

(5Z,7E)-(1S,3R,23R,25S)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone

(23R,25S)-1α,25-dihydroxyvitamin D3 26,23-lactone / (23R,25S)-1α,25-dihydroxycholecalciferol 26,23-lactone

(5Z,7E)-(1S,3R,23S,25S)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone

(23S,25S)-1α,25-dihydroxyvitamin D3 26,23-lactone / (23S,25S)-1α,25-dihydroxycholecalciferol 26,23-lactone

Calcitriol lactone

23S,25R)-1a,25-Dihydroxyvitamin D3 26,23-lactone

FA 23:3;O6

6-oxo-9S,11R,15S-trihydroxy-13E-prostenoic acid 1(3)-glyceryl ester

Superecdysone F

(20S,22R)-3beta,6,22,25-tetrahydroxycholest-5,8,14-trien-7-one

Asparacemosone B

(25R)-3,12-dioxo-5beta-spirostan-17alpha-ol

(23S,25R)-25-hydroxyvitamin D3 26,23-peroxylactone

(5Z,7E)-(3S,23S,25R)-3,25-dihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-peroxylactone

(23R,25R)-1alpha,25-dihydroxyvitamin D3 26,23-lactone

(5Z,7E)-(1S,3R,23R,25R)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone

(23S,25R)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23S,25R)-1alpha,25-dihydroxycholecalciferol 26,23-lactone

(23R,25S)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23R,25S)-1alpha,25-dihydroxycholecalciferol 26,23-lactone

(23S,25S)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23S,25S)-1alpha,25-dihydroxycholecalciferol 26,23-lactone

ST 27:4;O5

7alpha-Hydroxy-3,24-bisoxocholest-4-en-(25R)26-oyl-CoA

12-O-acetyl-16-O-deacetyl-16-epi-scalarobutenolide

(4S,5aS,5bR,7aS,11aS,11bR,13R,13aR,13bS)-4-hydroxy-5b,8,8,11a,13a-pentamethyl-2-oxo-2,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a,13b-octadecahydrochryseno[1,2-b]furan-13-yl acetate

A scalarane sesterterpenoid isolated from the marine sponge Hyrtios erectus that exhibits antineoplastic activity.

[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]diethylammonium acetate

C29H36N2O2 (444.2777)

2-(1-(4-(2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)propan- 2-yl)phenethyl)piperidin-4-yl)-1H-benzo[d]imidazole

C28H36N4O (444.2889)

9(11)-Dehydromanogenin

(3R,5S)-5-[(2R)-2-[(1R,3AR,4E,7AR)-4-[(2Z)-2-[(3S,5S)-3,5-Dihydroxy-2-methylidene-cyclohexylidene]ethylidene]-7A-methyl-2,3,3A,5,6,7-hexahydro-1H-inden-1-YL]propyl]-3-hydroxy-3-methyl-oxolan-2-one

D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

MG(6 keto-PGF1alpha/0:0/0:0)

MG(TXB2/0:0/0:0)

MG(0:0/TXB2/0:0)

(17-acetyl-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-1-yl) hexanoate

2-[(3Z,7E,12Z)-11,17-dihydroxy-1,4,8,12-tetramethyl-18-oxo-16-bicyclo[13.3.0]octadeca-3,7,12,16-tetraenyl]propyl acetate

1-[(2,4-dimethoxyphenyl)methyl]-N-(2-phenylethyl)-N-(phenylmethyl)-4-piperidinamine

C29H36N2O2 (444.2777)

Calcitriol 26,23-lactone

12-Deacetoxy-21-acetoxyscalarin

A scalarane sesterterpenoid isolated from the marine sponge Hyrtios erectus that exhibits antineoplastic activity.

1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea

1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea

1-[[(2R,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea

1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea

1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea

1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea

1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea

(1-acetyloxy-3-hydroxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

1,25-Dihydroxyvitamin D3-26,23-lactone

D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

2-glyceryl-6-keto-PGF1alpha

1(3)-glyceryl-6-keto-PGF1alpha

ST 23:0;O8

(4s,5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1-oxo-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4-yl acetate

4',16'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-11'-one

3,5-dihydroxy-4-{[2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-6-methyl-6-(3-methylbut-2-en-1-yl)-2-(3-methylbutanoyl)cyclohexa-2,4-dien-1-one

(3r,4s,5s,6r,7r,8r)-5,6,7-trihydroxy-2,2,4,6,8-pentamethyl-9-oxooxonan-3-yl (2e,4r)-4-hydroxydec-2-enoate

(2s)-2-[(3ar,13r,16as)-2,13-dihydroxy-3a,6,10,14-tetramethyl-3-oxo-4h,7h,8h,11h,12h,13h,16h,16ah-cyclopenta[15]annulen-1-yl]propyl acetate

4-hydroxy-3-{[2-(3-hydroxy-2-methylpropyl)-5a,9b-dimethyl-7-methylidene-octahydro-1h-naphtho[2,1-b]furan-6-yl]methyl}-5,6-dimethylpyran-2-one

8-(1-hydroxy-2,2,6-trimethylcyclohexyl)-6-methyl-2-[3-(5-oxo-2h-furan-3-yl)prop-2-en-1-ylidene]oct-5-en-1-yl acetate

4-hydroxy-3-{[3-(2-hydroxypropan-2-yl)-6a,10b-dimethyl-8-methylidene-decahydronaphtho[2,1-b]pyran-7-yl]methyl}-5,6-dimethylpyran-2-one

(1s,2r,3r,4ar,5s,8as)-4a,5-dimethyl-2-{[(3e)-3-methylpent-3-enoyl]oxy}-7-oxo-3-(prop-1-en-2-yl)-octahydronaphthalen-1-yl (3e)-3-methylpent-3-enoate

(5as,5br,7ar,9s,11ar,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1-oxo-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-9-yl acetate

(1'r,2r,2's,4's,5s,7's,8's,9's,12's,13'r)-5,8'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-17'-en-16'-one

(1'r,2r,2's,4's,5r,7's,8's,9'r,10'r,12's,13'r)-8',10'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-17'-en-16'-one

1-[(2r,3r,4r,5r)-2-[(7s,8s)-8-[(2r)-1-acetylpiperidin-2-yl]-7,8-dihydroxyoctyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-1-yl]ethanone

C22H40N2O7 (444.2835)

3,26-dihydroxycholest-5-ene-12,16,22-trione